PA
ARRY
Pinnacle Associates’s Array Biopharma Inc ARRY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-837,563
| Closed | -$38.8M | – | 735 |
|
2019
Q2 | $38.8M | Sell |
837,563
-942,321
| -53% | -$43.7M | 0.91% | 22 |
|
2019
Q1 | $43.4M | Sell |
1,779,884
-51,275
| -3% | -$1.25M | 0.98% | 20 |
|
2018
Q4 | $26.1M | Sell |
1,831,159
-96,377
| -5% | -$1.37M | 0.67% | 41 |
|
2018
Q3 | $29.3M | Sell |
1,927,536
-291,488
| -13% | -$4.43M | 0.61% | 47 |
|
2018
Q2 | $37.2M | Sell |
2,219,024
-379,804
| -15% | -$6.37M | 0.77% | 32 |
|
2018
Q1 | $42.4M | Sell |
2,598,828
-118,155
| -4% | -$1.93M | 0.83% | 30 |
|
2017
Q4 | $34.8M | Sell |
2,716,983
-251,125
| -8% | -$3.21M | 0.67% | 41 |
|
2017
Q3 | $36.5M | Sell |
2,968,108
-84,340
| -3% | -$1.04M | 0.67% | 41 |
|
2017
Q2 | $25.5M | Sell |
3,052,448
-11,129
| -0.4% | -$93.2K | 0.49% | 60 |
|
2017
Q1 | $27.4M | Sell |
3,063,577
-145,930
| -5% | -$1.3M | 0.52% | 47 |
|
2016
Q4 | $28.2M | Sell |
3,209,507
-185,310
| -5% | -$1.63M | 0.57% | 47 |
|
2016
Q3 | $22.9M | Sell |
3,394,817
-99,310
| -3% | -$670K | 0.46% | 67 |
|
2016
Q2 | $12.4M | Sell |
3,494,127
-25,140
| -0.7% | -$89.5K | 0.27% | 103 |
|
2016
Q1 | $10.4M | Buy |
3,519,267
+65,780
| +2% | +$194K | 0.22% | 121 |
|
2015
Q4 | $14.6M | Sell |
3,453,487
-256,933
| -7% | -$1.08M | 0.31% | 90 |
|
2015
Q3 | $16.9M | Sell |
3,710,420
-109,633
| -3% | -$500K | 0.37% | 69 |
|
2015
Q2 | $27.5M | Sell |
3,820,053
-126,430
| -3% | -$912K | 0.51% | 55 |
|
2015
Q1 | $29.1M | Buy |
3,946,483
+19,515
| +0.5% | +$144K | 0.54% | 47 |
|
2014
Q4 | $18.6M | Buy |
3,926,968
+197,745
| +5% | +$935K | 0.36% | 76 |
|
2014
Q3 | $13.3M | Buy |
3,729,223
+1,129,290
| +43% | +$4.03M | 0.27% | 101 |
|
2014
Q2 | $11.9M | Sell |
2,599,933
-250,090
| -9% | -$1.14M | 0.23% | 104 |
|
2014
Q1 | $13.4M | Sell |
2,850,023
-100,240
| -3% | -$471K | 0.26% | 97 |
|
2013
Q4 | $14.8M | Buy |
2,950,263
+619,483
| +27% | +$3.1M | 0.29% | 93 |
|
2013
Q3 | $14.5M | Buy |
+2,330,780
| New | +$14.5M | 0.3% | 89 |
|